Delivery Order SPE2DB22D1103-SPE2DB23FE5HT
Award Date 8/11/23
Potential Completion Date 9/1/23
Potential Value $7.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency Troop Support Medical awarded a $7,845.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 140 mg capsules of IMBRUVICA to treat cancer. The product will be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania to an unknown customer by July 28, 2023. No subcontractors or set aside designations were identified. This order is likely in support of the Defense Health Agency's cancer treatment programs and was issued through...
- The Defense Logistics Agency Troop Support Medical awarded a $7,845.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 140 mg capsules of IMBRUVICA to treat cancer. The prime contractor will deliver 90 capsules to a facility in Conshohocken, Pennsylvania by August 7, 2023 to fulfill the Defense Logistics Agency's requirements under an existing contract vehicle. No set aside designation or subcontractors were identified for this order to supply pharmaceutical products in...
- The Defense Logistics Agency Troop Support Medical awarded a $7,845.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 140 mg capsules of IMBRUVICA to treat cancer. The prime contractor is to provide 90 capsules of the pharmaceutical product, with performance taking place in Conshohocken, Pennsylvania between September 26 and October 18, 2023. No major subcontractors or set aside designations were indicated. This delivery order was issued under an existing prime...
- The Defense Logistics Agency Troop Support Medical awarded a $7,845.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 140 mg capsules of IMBRUVICA to treat cancer. The contract requires Amerisourcebergen to deliver 90 capsules of IMBRUVICA to a facility in Conshohocken, Pennsylvania by August 30th, with performance starting on August 9th. No set aside designation or subcontractors were specified. This delivery order was issued under an existing DLA medical product...
- The Defense Logistics Agency issued a $7,793.26 delivery order to Amerisourcebergen Drug Corp on March 17, 2026, for IMBRUVICA 280 mg tablets. The order is issued under the company's Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2026, which provides pharmaceutical and medical supplies for military healthcare programs globally. Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,575.75 for IMBRUVICA 140 mg tablets (28-count supply) on August 28, 2025, with completion scheduled for September 19, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,575.75 to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 420 mg tablets (28-count units) with delivery to Conshohocken, Pennsylvania. This contract, awarded on August 4, 2025, utilizes a firm fixed-price structure with an ultimate completion date of August 25, 2025. The award was made without a set-aside designation, indicating it was competitively awarded among qualified vendors. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $41,831.16 to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 280 mg tablets (28-count packaging) on January 29, 2026. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of February 20, 2026, and does not include any set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime...
- The Defense Logistics Agency awarded a $15,967.36 delivery order to AmerisourceBergen Drug Corp for 28-tablet containers of Imbruvica 420 mg on October 27, 2025, with completion scheduled for November 18, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive procurement under the company's broader pharmaceutical supply relationship with the federal government. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $7,983.68 delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Imbruvica 280 mg tablets (28-count) with a completion date of December 3, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB23FE5HTDelivery Order
The Defense Logistics Agency awarded a $7,322.67 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 28 packages containing 280 mg tablets of IMBRUVICA to treat cancer. The order is under an indefinite-delivery/indefinite-quantity contract vehicle and will be fulfilled from Amerisourcebergen's facility located in Conshohocken, Pennsylvania by September 1, 2023 to support the Department of Defense's medical readiness and treatment programs. No subcontractors or set aside designations were identified.
Generated 12/19/23, 7:01 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 8/11/23 |